To further explore the potential mechanism of XXMD in the treatment of stroke, we constructed a comprehensive pathway with these four pathways, VEGF signaling pathway (hsa04370), MAPK signaling pathway (hsa04010), PI3K-Akt signaling pathway (hsa04151), and cAMP signaling pathway (hsa04024) (Figure 9). The gene discussed is AKT1; the disease is stroke disorder.